Journal article
CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy
Current opinion in investigational drugs (London, England : 2000), Vol.4(6), pp.686-690
06/2003
PMID: 12901226
Abstract
Synthetic oligodeoxynucleotides containing CG motifs (CpG ODNs) have potent immunostimulatory properties, and have potential as immunotherapeutic agents in cancer. Animal models suggest that CpG ODNs may be useful as both single agents and to enhance the efficacy of monoclonal antibody therapy. CpG ODNs can also enhance the efficacy of tumor immunization through use as an immune adjuvant, to activate antigen presenting cells, or as a component of DNA vaccines. Clinical trials are now beginning to assess whether the promise of these agents in the laboratory will translate into CpG ODNs becoming a valuable component of clinical cancer immunotherapy.
Details
- Title: Subtitle
- CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy
- Creators
- Bernd Jahrsdörfer - Holden Comprehensive Cancer Center, Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USAGeorge J Weiner
- Resource Type
- Journal article
- Publication Details
- Current opinion in investigational drugs (London, England : 2000), Vol.4(6), pp.686-690
- PMID
- 12901226
- ISSN
- 1472-4472
- Language
- English
- Date published
- 06/2003
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Pharmaceutical Sciences and Experimental Therapeutics; Internal Medicine
- Record Identifier
- 9984094757802771
Metrics
16 Record Views